glp 1 mimetic mechanism of action GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Mechanisms of action and effects

Super effective, even at the starting dose

Combining MOTS-c with 5-Amino-1MQ creates synergistic metabolic enhancement by targeting two distinct but complementary pathways: MOTS-c activates AMPK to increase mitochondrial biogenesis and insulin sensitivity, while 5-Amino-1MQ inhibits NNMT to preserve NAD+ levels, which fuel the very pathways MOTS-c activates

Related Peptides Additional -MSH derivatives are also being heavily studied, namely melanotan 1 (MT-I)

Retatrutide GI side effects tend to be more pronounced at equivalent efficacy levels, likely due to the additional glucagon-mediated GI motility effects layered on top of the GLP-1 gastric slowing